Worldwide Clinical Trials

NCT01244438

Study of FP-1039 in Subjects With Endometrial Cancers

NCT01660633

Safety & Efficacy Study High Dose Evomela Injection for MA Conditioning in MM Patients With Autologous Transplantation

NCT02151643

Study to Evaluate the Efficacy and Safety of PT20 in Subjects With Hyperphosphataemia and Dialysis Dependent Chronic Kidney Disease

NCT02037555

Safety and Efficacy of Preoperative Antithrombin Supplementation in Patients Undergoing High-Risk Cardiopulmonary Bypass

NCT02782858

Clinical Trial Assessing the HERV-W Env Antagonist GNbAC1 for Efficacy in MS

NCT02966028

Effect of SNF472 on Progression of Cardiovascular Calcification in End-Stage-Renal-Disease (ESRD) Patients on Hemodialysis (HD)

NCT03239860

Assessing the HERV-W Env ANtagonist GNbAC1 for Evaluation in an Open Label Long-term Safety Study in Patients With Multiple Sclerosis

NCT03113825

Study of AVB-620 in Women With Primary, Nonrecurrent Breast Cancer Undergoing Surgery

NCT03402659

Proof-of-Concept Study of a Selective p38 MAPK Alpha Inhibitor, Neflamapimod, in Subjects With Mild Alzheimer's Disease

NCT03574363

Phase 2b Study of KBP-5074 in Subjects With Uncontrolled Hypertension and Advanced Chronic Kidney Disease

NCT03560245

A Study of Bryostatin in Moderately Severe to Severe Alzheimer's Disease Subjects Not On Memantine

NCT03613662

A Research Study to Characterize the Pharmacodynamics and Safety of Repeat Dose SP-102

NCT04001517

Cognitive Effects of Oral p38 Alpha Kinase Inhibitor Neflamapimod in Dementia With Lewy Bodies

NCT04146896

Efficacy and Safety of NYX-2925 in Subjects With Neuropathic Pain Associated With Diabetic Peripheral Neuropathy (DPN)

NCT04147858

Efficacy and Safety of NYX-2925 in Subjects With Fibromyalgia

NCT04148391

NYX-458 in Subjects With Mild Cognitive Impairment or Mild Dementia Due to Parkinson's Disease or Lewy Body Dementia (Cognition, Memory, Attention, Thinking)

NCT04334460

Safety and Antiviral Activity of BLD-2660 in COVID-19 Hospitalized Subjects

NCT04567524

A Multiple Dose Study to Assess the Safety, Tolerability and PK of Risperidone Extended Release Capsules

NCT04652518

LYT-100 in Post-acute COVID-19 Respiratory Disease

NCT04762069

A Study of Berubicin in Adult Subjects With Recurrent Glioblastoma Multiforme

NCT05133518

A Study of MELT-300 (Midazolam and Ketamine Sublingual Tablets) for Sedation and Intraoperative Ocular Analgesia in Participants Undergoing Cataract Extraction With Lens Replacement (CELR)

NCT04531579

Valproic Acid (VPA) for Acute Kidney Injury (AKI) in Trauma Patients

NCT04531592

Valproic Acid (VPA) for Acute Kidney Injury (AKI) in Liver Transplant Patients

NCT05096494

Safety and Efficacy of SP-103 in Subjects With Moderate to Severe Acute Lower Back Pain

NCT05224531

Effect of CS1 in Subjects With Pulmonary Arterial Hypertension

NCT05514548

Phase 2 Study of INV-202 in Patients With Diabetic Kidney Disease

NCT05869669

RewinD-LB - Clinical Study of Neflamapimod in Patients With Dementia With Lewy Bodies

NCT04213274

Study of the Efficacy and Safety of RPH-104 in Adult Subjects With Schnitzler Syndrome

NCT06051721

A Study of a N, N-dimethyltryptamine (DMT) Analog (CYB004) in Participants with Generalized Anxiety Disorder (GAD)

NCT06671938

Safety, Tolerability, and Pharmacokinetics of Exidavnemab in Patients With Parkinson's Disease and Patients With Multiple System Atrophy

NCT06547489

GATE-251 or Placebo for the Reduction of Symptoms of Major Depressive Disorder

NCT06815471

CRF2 Agonist for the Treatment of Worsening Heart Failure

NCT07115329

GATE-251 or Placebo for the Reduction of Symptoms of Major Depressive Disorder With Comorbid Anxiety and Insomnia